0000000001003830

AUTHOR

Roberto Giuseppetti

showing 2 related works from this author

A potential host and virus targeting tool against COVID-19: Chemical characterization, antiviral, cytoprotective, antioxidant, respiratory smooth mus…

2023

COronaVIrus Disease 2019 (COVID-19) is a newly emerging infectious disease that spread across the world, caused by the novel coronavirus Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Despite the advancements in science that led to the creation of the vaccine, there is still an urgent need for new antiviral drugs effective against SARS-CoV-2. This study aimed to investigate the antiviral effect of Paulownia tomentosa Steud extract against SARS-CoV-2 and to evaluate its antioxidant properties, including respiratory smooth muscle relaxant effects. Our results showed that P. tomentosa extract can inhibit viral replication by directly interacting with both the 3-chymotrypsin-like…

Pharmacologysars-cov-2covid-19antioxydantcovid-19; paulownia tomentosa steud extract; antiviral; antioxydant; phytocomplex; sars-cov-2paulownia tomentosa steud extractGeneral MedicinephytocomplexantiviralBiomedicine & Pharmacotherapy
researchProduct

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.

1992

Objective To determine whether chronic hepatitis C virus (HCV) infection is an independent risk factor for hepatocellular carcinoma and whether it increases the cirrhosis-related risk for hepatocellular carcinoma. Design Two pair-matched case-control studies. Setting A referral-based hospital. Patients In study I, 212 patients with hepatocellular carcinoma (197 of whom had known underlying cirrhosis) were compared with controls who had chronic nonhepatic diseases. In study II, the 197 patients with hepatocellular carcinoma and cirrhosis were compared with 197 pair-matched controls who had cirrhosis but not hepatocellular carcinoma. Measurements Levels of antibody to HCV (anti-HCV), hepatiti…

Liver CirrhosisMalemedicine.medical_specialtyHBsAgCirrhosisCarcinoma HepatocellularHepatitis C virusHepacivirusmedicine.disease_causeGastroenterologyRisk FactorsInternal medicineInternal MedicinemedicineCarcinomaPrevalenceHumansHepatitis AntibodiesRisk factorHepatitis B AntibodiesSicilyAgedHepatitis B Surface Antigensbusiness.industryLiver NeoplasmsCase-control studyGeneral MedicineOdds ratioMiddle Agedmedicine.diseaseHepatitis B Core AntigensHepatitis Cdigestive system diseasesHepatocellular carcinomaCase-Control StudiesFemalebusinessAnnals of internal medicine
researchProduct